Coronary interventions

Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration

EuroIntervention 2016;11:e1222-e1230 - published online ahead of print August 2015 - published online e-edition February 2016. DOI: 10.4244/EIJY15M08_04

Francesco Costa1, MD; Marianna Adamo1, MD; Sara Ariotti1, MD; Giuseppe Ferrante2, MD, PhD; Eliano Pio Navarese3, MD, PhD; Sergio Leonardi4, MD; Hector Garcia-Garcia5, MD, PhD; Pascal Vranckx6, MD, PhD; Marco Valgimigli1*, MD, PhD

1. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Interventional Cardiology, Humanitas Clinical and Research Institute IRCCS, Milan, Italy; 3. Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine

Aims: It is currently unclear if the location of coronary artery disease affects decision making with regard to dual antiplatelet therapy (DAPT). We investigated if the presence of at lea

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

acute coronary syndromeclopidogreldual antiplatelet therapy (dapt)left main coronary arteryproximal left anterior descending coronary arterystent thrombosis

Coronary interventionsLeft main and multivessel diseaseAdjunctive pharmacotherapy

Share on Facebook Share on Twitter Share on Linkedin